{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:36:23Z","timestamp":1790116583397,"version":"4.0.1"},"reference-count":103,"publisher":"Elsevier","isbn-type":[{"value":"9780128002827","type":"print"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1016\/bs.apha.2014.06.004","type":"book-chapter","created":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T06:27:26Z","timestamp":1408688846000},"page":"277-299","source":"Crossref","is-referenced-by-count":53,"title":["Delivery of Therapeutic Peptides and Proteins to the CNS"],"prefix":"10.1016","author":[{"given":"Therese S.","family":"Salameh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/bs.apha.2014.06.004_bb0005","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.neuint.2003.11.006","article-title":"Evidence for bulk flow of brain interstitial fluid: Significance for physiology and pathology","volume":"45","author":"Abbott","year":"2004","journal-title":"Neurochemistry International"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nature Reviews. Neuroscience"},{"issue":"4","key":"10.1016\/bs.apha.2014.06.004_bb0015","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1602\/neurorx.2.4.554","article-title":"Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery","volume":"2","author":"Alavijeh","year":"2005","journal-title":"NeuroRx"},{"issue":"10","key":"10.1016\/bs.apha.2014.06.004_bb0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10611860500411043","article-title":"Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats","volume":"13","author":"Ambruosi","year":"2005","journal-title":"Journal of Drug Targeting"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2005.12.035","article-title":"Effects of lipopolysaccharide on blood-brain barrier permeability during pentylenetetrazole-induced epileptic seizures in rats","volume":"79","author":"Arican","year":"2006","journal-title":"Life Sciences"},{"issue":"84","key":"10.1016\/bs.apha.2014.06.004_bb0030","doi-asserted-by":"crossref","first-page":"84ra43","DOI":"10.1126\/scitranslmed.3002254","article-title":"A therapeutic antibody targeting BACE1 inhibits amyloid-\u03b2 production in vivo","volume":"3","author":"Atwal","year":"2011","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.apha.2014.06.004_bb0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0006-8993(01)02242-9","article-title":"Enhanced leptin transport across the blood-brain barrier by alpha1-adrenergic agents","volume":"899","author":"Banks","year":"2001","journal-title":"Brain Research"},{"key":"10.1016\/bs.apha.2014.06.004_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2004.10.035","article-title":"Passage of erythropoietic agents across the blood-brain barrier: A comparison of human and murine erythropoietin and the analog Darbopoetin alpha","volume":"505","author":"Banks","year":"2004","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2014.06.004_bb0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0361-9230(85)90153-4","article-title":"Peptides and the blood-brain barrier: Lipophilicity as a predictor of permeability","volume":"15","author":"Banks","year":"1985","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/bs.apha.2014.06.004_bb0050","first-page":"223","article-title":"Peptide binding in blood and passage across the blood\u2013brain barrier","author":"Banks","year":"1993"},{"key":"10.1016\/bs.apha.2014.06.004_bb0055","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0091-3057(82)90486-5","article-title":"Delta sleep-inducing peptide crosses the blood-brain-barrier in dogs: Some correlations with protein binding","volume":"17","author":"Banks","year":"1982","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/bs.apha.2014.06.004_bb0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbi.2003.09.013","article-title":"Permeability of the mouse blood-brain barrier to murine interleukin-2: Predominance of a saturable efflux system","volume":"18","author":"Banks","year":"2004","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/bs.apha.2014.06.004_bb0070","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0196-9781(02)00261-9","article-title":"Transport of amyloid protein antibody across the blood-brain barrier in an animal model of Alzheimer's disease","volume":"23","author":"Banks","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/bs.apha.2014.06.004_bb0075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/jcbfm.1987.137","article-title":"Characteristics of aminopeptidase activity from bovine brain microvessel endothelium","volume":"7","author":"Baranczyk-Kuzma","year":"1987","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"0","key":"10.1016\/bs.apha.2014.06.004_bb0080","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2012.06.054","article-title":"Brain-blood barrier breakdown and pro-inflammatory mediators in neonate rats submitted meningitis by Streptococcus pneumoniae","volume":"1471","author":"Barichello","year":"2012","journal-title":"Brain Research"},{"key":"10.1016\/bs.apha.2014.06.004_bb0085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0361-9230(87)90048-7","article-title":"D-[Ala 1]-peptide T-amide is transported from blood to brain by a saturable system","volume":"19","author":"Barrera","year":"1987","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/bs.apha.2014.06.004_bb0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0168-3659(94)90075-2","article-title":"Strategies for delivery of peptide drugs to the central nervous system: Exploiting molecular structure","volume":"29","author":"Begley","year":"1994","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00137696-200301010-00002","article-title":"Brain-targeted drug delivery","volume":"1","author":"Bodor","year":"2003","journal-title":"American Journal of Drug Delivery"},{"key":"10.1016\/bs.apha.2014.06.004_bb0100","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0022-3565(25)22398-9","article-title":"Effect of peptidases at the blood brain barrier on the permeability of enkephalin","volume":"270","author":"Brownson","year":"1994","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1113\/jphysiol.1990.sp018243","article-title":"Electrical resistance across the blood-brain barrier in anaesthetized rats: A developmental study","volume":"429","author":"Butt","year":"1990","journal-title":"The Journal of Physiology"},{"key":"10.1016\/bs.apha.2014.06.004_bb0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1023\/A:1018969222130","article-title":"Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides","volume":"11","author":"Chikhale","year":"1994","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/bs.apha.2014.06.004_bb0115","doi-asserted-by":"crossref","first-page":"C161","DOI":"10.1152\/ajpcell.1982.243.3.C161","article-title":"Comparison of lipid-mediated blood-brain-barrier penetrability in neonates and adults","volume":"243","author":"Cornford","year":"1982","journal-title":"American Journal of Physiology"},{"key":"10.1016\/bs.apha.2014.06.004_bb0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0005-2736(75)90259-X","article-title":"Independent blood-brain barrier transport systems for nucleic acid precursors","volume":"394","author":"Cornford","year":"1975","journal-title":"Biochimica et Biophysica Acta"},{"issue":"183","key":"10.1016\/bs.apha.2014.06.004_bb0125","doi-asserted-by":"crossref","first-page":"183ra157","DOI":"10.1126\/scitranslmed.3005338","article-title":"Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier","volume":"5","author":"Couch","year":"2013","journal-title":"Science Translational Medicine"},{"issue":"4","key":"10.1016\/bs.apha.2014.06.004_bb0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1085\/jgp.77.4.349","article-title":"Electrical resistance of a capillary endothelium","volume":"77","author":"Crone","year":"1981","journal-title":"The Journal of General Physiology"},{"key":"10.1016\/bs.apha.2014.06.004_bb0135","series-title":"Cerebral angiogenesis","first-page":"415","article-title":"In vitro models of the blood-brain barrier","volume":"Vol. 1135","author":"Czupalla","year":"2014"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.004_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(01)01640-8","article-title":"Uptake and efflux of the peptidic delta-opioid receptor agonist [D-penicillamine2,5]-enkephalin at the murine blood-brain barrier by in situ perfusion","volume":"301","author":"Dagenais","year":"2001","journal-title":"Neuroscience Letters"},{"issue":"7323","key":"10.1016\/bs.apha.2014.06.004_bb0145","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nature09513","article-title":"Pericytes are required for blood\u2013brain barrier integrity during embryogenesis","volume":"468","author":"Daneman","year":"2010","journal-title":"Nature"},{"key":"10.1016\/bs.apha.2014.06.004_bb0150","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-2143(98)90048-8","article-title":"Brain endothelial cell enzymes cleave platelet-retained amyloid precursor protein","volume":"132","author":"Davies","year":"1998","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10.1016\/bs.apha.2014.06.004_bb0155","first-page":"303","author":"Davson","year":"1996","journal-title":"Special aspects of the blood-brain barrier physiology of the CSF and blood-brain barriers"},{"key":"10.1016\/bs.apha.2014.06.004_bb0160","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1056\/NEJM199109053251006","article-title":"Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay","volume":"325","author":"De Vivo","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.004_bb0165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/bs.apha.2014.06.004_bb0170","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.bbamem.2008.09.016","article-title":"Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery","volume":"1788","author":"Deli","year":"2009","journal-title":"Biochimica et Biophysica Acta (BBA)- Biomembranes"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0175","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/npp.2011.196","article-title":"Transferrin antibodies into the brain","volume":"37","author":"Dennis","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.apha.2014.06.004_bb0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/B978-0-12-024911-4.50010-6","article-title":"Uptake and transport of fatty acids into the brain and the role of the blood-brain barrier system","volume":"11","author":"Dhopeshwarkar","year":"1973","journal-title":"Advances in Lipid Research"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.004_bb0185","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1096\/fj.05-3956com","article-title":"A\u03b2 peptide immunization restores blood-brain barrier integrity in Alzheimer disease","volume":"20","author":"Dickstein","year":"2006","journal-title":"The FASEB Journal"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.004_bb0190","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.102.039255","article-title":"Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs","volume":"303","author":"Doan","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.004_bb0195","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/jcbfm.2008.131","article-title":"Isolation of peptide transport system-6 from brain endothelial cells: Therapeutic effects with antisense inhibition in Alzheimer and stroke models","volume":"29","author":"Dogrukol-Ak","year":"2008","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2045-8118-10-23","article-title":"Brain pericytes increase the lipopolysaccharide-enhanced transcytosis of HIV-1 free virus across the in vitro blood-brain barrier: Evidence for cytokine-mediated pericyte-endothelial cell crosstalk","volume":"10","author":"Dohgu","year":"2013","journal-title":"Fluids and Barriers of the CNS"},{"issue":"7","key":"10.1016\/bs.apha.2014.06.004_bb0205","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/sj.bjp.0705554","article-title":"Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries","volume":"140","author":"Erdlenbruch","year":"2003","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2014.06.004_bb0210","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1517\/13543784.2012.679339","article-title":"Investigational ABC transporter inhibitors","volume":"21","author":"Falasca","year":"2012","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"11","key":"10.1016\/bs.apha.2014.06.004_bb0215","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1073\/pnas.88.11.4771","article-title":"Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier","volume":"88","author":"Friden","year":"1991","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"10.1016\/bs.apha.2014.06.004_bb0220","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s11095-013-1122-4","article-title":"Targeted delivery of nano-therapeutics for major disorders of the central nervous system","volume":"30","author":"Gao","year":"2013","journal-title":"Pharmaceutical Research"},{"issue":"10","key":"10.1016\/bs.apha.2014.06.004_bb0225","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0196-9781(99)00127-8","article-title":"The effect of halogenation on blood-brain barrier permeability of a novel peptide drug","volume":"20","author":"Gentry","year":"1999","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/bs.apha.2014.06.004_bb0230","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/01.WCB.0000135592.28823.47","article-title":"Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion","volume":"24","author":"Gosk","year":"2004","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(02)00633-8","article-title":"The superfamily of organic anion transporting polypeptides","volume":"1609","author":"Hagenbuch","year":"2003","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ana.410080102","article-title":"Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface","volume":"8","author":"Hardebo","year":"1980","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.apha.2014.06.004_bb0245","series-title":"Pathophysiology of the blood-brain barrier","first-page":"41","article-title":"Enzymatic barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain barrier","author":"Hardebo","year":"1990"},{"key":"10.1016\/bs.apha.2014.06.004_bb0250","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.109.061754","article-title":"Restoring blood-brain barrier p-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease","volume":"77","author":"Hartz","year":"2010","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/bs.apha.2014.06.004_bb0255","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1399-3011.1994.tb00165.x","article-title":"Structure-activity and conformational studies of a series of modified C-terminal hexapeptide neurotensin analogues","volume":"44","author":"Heyl","year":"1994","journal-title":"International Journal of Peptide and Protein Research"},{"issue":"3\u20134","key":"10.1016\/bs.apha.2014.06.004_bb0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0923-2508(01)01193-7","article-title":"ABC transporters: Physiology, structure and mechanism\u2014An overview","volume":"152","author":"Higgins","year":"2001","journal-title":"Research in Microbiology"},{"issue":"0","key":"10.1016\/bs.apha.2014.06.004_bb0265","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.brainres.2010.10.002","article-title":"Lentivirus-mediated transfer of MMP-9 shRNA provides neuroprotection following focal ischemic brain injury in rats","volume":"1367","author":"Hu","year":"2011","journal-title":"Brain Research"},{"issue":"7","key":"10.1016\/bs.apha.2014.06.004_bb0270","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/bph.12218","article-title":"Acute effects of short-chain alkylglycerols on blood-brain barrier properties of cultured brain endothelial cells","volume":"169","author":"H\u00fclper","year":"2013","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2014.06.004_bb0275","first-page":"147","article-title":"Studies on the blood-brain barrier. II. Attempts to influence the passage of substances into the brain","volume":"5","author":"Hurst","year":"1950","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.004_bb0280","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0006-8993(93)91064-Y","article-title":"Human fetal astrocytes induce the expression of blood-brain barrier specific proteins by autologous endothelial cells","volume":"625","author":"Hurwitz","year":"1993","journal-title":"Brain Research"},{"key":"10.1016\/bs.apha.2014.06.004_bb0285","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/jcbfm.1992.14","article-title":"Exercise and the brain: Angiogenesis in the adult rat cerebellum after vigorous physical activity and motor skill learning","volume":"12","author":"Isaacs","year":"1992","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"5990","key":"10.1016\/bs.apha.2014.06.004_bb0290","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/312162a0","article-title":"Transferrin receptor on endothelium of brain capillaries","volume":"312","author":"Jefferies","year":"1984","journal-title":"Nature"},{"issue":"10\u201311","key":"10.1016\/bs.apha.2014.06.004_bb0295","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/00498250701570285","article-title":"Challenges for blood-brain barrier (BBB) screening","volume":"37","author":"Jeffrey","year":"2007","journal-title":"Xenobiotica"},{"issue":"9","key":"10.1016\/bs.apha.2014.06.004_bb0300","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI11013","article-title":"Modulation of amyloid \u03b2-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway","volume":"106","author":"Kang","year":"2000","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0305","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.jcbfm.9600330","article-title":"HIV-1 gp120 compromises blood-brain barrier integrity and enhance monocyte migration across blood-brain barrier: Implication for viral neuropathogenesis","volume":"27","author":"Kanmogne","year":"2006","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"4","key":"10.1016\/bs.apha.2014.06.004_bb0310","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0091-3057(91)90084-F","article-title":"EEG evidence that morphine and an enkephalin analog cross the blood-brain barrier","volume":"40","author":"Kastin","year":"1991","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"31","key":"10.1016\/bs.apha.2014.06.004_bb0315","doi-asserted-by":"crossref","first-page":"11719","DOI":"10.1073\/pnas.0604318103","article-title":"Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption","volume":"103","author":"Kinoshita","year":"2006","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.004_bb0320","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbamem.2007.10.018","article-title":"Structure and function of claudins","volume":"1778","author":"Krause","year":"2008","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"issue":"6","key":"10.1016\/bs.apha.2014.06.004_bb0325","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1021\/jm00180a022","article-title":"Relationship of octanol\/water partition coefficient and molecular weight to rat brain capillary permeability","volume":"23","author":"Levin","year":"1980","journal-title":"Journal of Medicinal Chemistry"},{"issue":"8","key":"10.1016\/bs.apha.2014.06.004_bb0330","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1755-5949.2012.00340.x","article-title":"Tight junction in blood-brain barrier: An overview of structure, regulation, and regulator substances","volume":"18","author":"Liu","year":"2012","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0335","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1471-4159.2000.0740320.x","article-title":"Affinity purification and partial characterization of the zonulin\/zonula occludens toxin (Zot) receptor from human brain","volume":"74","author":"Lu","year":"2000","journal-title":"Journal of Neurochemistry"},{"issue":"7","key":"10.1016\/bs.apha.2014.06.004_bb0340","doi-asserted-by":"crossref","first-page":"e22598","DOI":"10.1371\/journal.pone.0022598","article-title":"Noninvasive, transient and selective blood-brain barrier opening in non-human primates in vivo","volume":"6","author":"Marquet","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2014.06.004_bb0345","first-page":"E1083","article-title":"Transport of CRH from mouse brain directly affects peripheral production of\u00b7beta-endorphin by the spleen","volume":"273","author":"Martins","year":"1997","journal-title":"American Journal of Physiology"},{"key":"10.1016\/bs.apha.2014.06.004_bb0350","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00966664","article-title":"The effect of age on lipid composition and order of rat cerebral microvessels","volume":"17","author":"Mooradian","year":"1992","journal-title":"Neurochemical Research"},{"key":"10.1016\/bs.apha.2014.06.004_bb0355","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0304-3940(92)90007-T","article-title":"The effect of experimentally induced diabetes mellitus on the lipid order and composition of rat cerebral microvessels","volume":"145","author":"Mooradian","year":"1992","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.apha.2014.06.004_bb0360","unstructured":"Nag, S. (2011). Morphology and properties of brain endothelial cells. In S. Nag (Ed.), Vol. 686. The blood-brain and other neural barriers (pp. 3\u201347). New Jersey: Humana Press."},{"issue":"4_Part_1","key":"10.1016\/bs.apha.2014.06.004_bb0365","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7326\/0003-4819-94-4-449","article-title":"Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption","volume":"94","author":"Neuwelt","year":"1981","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0370","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","article-title":"Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle","volume":"81","author":"Niewoehner","year":"2014","journal-title":"Neuron"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2014.06.004_bb0375","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0165-5728(01)00256-9","article-title":"Changing the chemokine gradient: CINC1 crosses the blood-brain barrier","volume":"115","author":"Pan","year":"2001","journal-title":"Journal of Neuroimmunology"},{"issue":"4","key":"10.1016\/bs.apha.2014.06.004_bb0380","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0896-6273(02)01054-1","article-title":"Drug and gene delivery to the brain: The vascular route","volume":"36","author":"Pardridge","year":"2002","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0385","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: Bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"issue":"11","key":"10.1016\/bs.apha.2014.06.004_bb0390","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0395","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2045-8118-8-21","article-title":"Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent","volume":"8","author":"Pascale","year":"2011","journal-title":"Fluids and Barriers of the CNS"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.004_bb0400","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11481-006-9025-3","article-title":"Blood-brain barrier: Structural components and function under physiologic and pathologic conditions","volume":"1","author":"Persidsky","year":"2006","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2014.06.004_bb0405","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0301-0082(02)00128-4","article-title":"Junctional complexes of the blood-brain barrier: Permeability changes in neuroinflammation","volume":"68","author":"Petty","year":"2002","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/bs.apha.2014.06.004_bb0410","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0741-8329(97)00083-9","article-title":"Enkephalin, PPE, mRNA, and PTS-1 in alcohol withdrawal seizure-prone and -resistant mice","volume":"15","author":"Plotkin","year":"1998","journal-title":"Alcohol"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.004_bb0415","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0169-328X(94)90222-4","article-title":"Glycation increases the permeability of proteins across the blood-nerve and blood-brain barriers","volume":"1","author":"Poduslo","year":"1994","journal-title":"Brain Research. Molecular Brain Research"},{"issue":"10","key":"10.1016\/bs.apha.2014.06.004_bb0420","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1096\/fj.01-0814fje","article-title":"Angiogenesis of the blood-brain barrier in vitro and the function of cerebral pericytes","volume":"16","author":"Ramsauer","year":"2002","journal-title":"The FASEB Journal"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0425","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2006.01.003","article-title":"Tight junction modulation and its relationship to drug delivery","volume":"58","author":"Salama","year":"2006","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.004_bb0430","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1006\/mvre.1999.2188","article-title":"Microvessel organization and structure in experimental brain tumors: Microvessel populations with distinctive structural and functional properties","volume":"58","author":"Schlageter","year":"1999","journal-title":"Microvascular Research"},{"key":"10.1016\/bs.apha.2014.06.004_bb0435","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/13506129809003841","article-title":"Blood brain barrier endothelial cells express candidate amyloid precursor protein-cleaving secretases","volume":"5","author":"Simons","year":"1998","journal-title":"Amyloid"},{"key":"10.1016\/bs.apha.2014.06.004_bb0440","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/j.1471-4159.1987.tb01039.x","article-title":"Kinetics of neutral amino acid transport across the blood-brain barrier","volume":"49","author":"Smith","year":"1987","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0445","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-3565(24)36406-7","article-title":"Structure-internalization relationship for adsorptive-mediated endocytosis of basic peptides at the blood-brain barrier","volume":"280","author":"Tamai","year":"1997","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"12","key":"10.1016\/bs.apha.2014.06.004_bb0450","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1242\/jcs.01235","article-title":"Barriers built on claudins","volume":"117","author":"Turksen","year":"2004","journal-title":"Journal of Cell Science"},{"key":"10.1016\/bs.apha.2014.06.004_bb0455","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0006-8993(96)00716-0","article-title":"Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide","volume":"736","author":"Uchida","year":"1996","journal-title":"Brain Research"},{"key":"10.1016\/bs.apha.2014.06.004_bb0460","doi-asserted-by":"crossref","first-page":"12873","DOI":"10.1073\/pnas.0705611104","article-title":"Epinephrine enhances lysosomal enzyme delivery across the blood-brain barrier by up-regulation of the mannose 6-phosphate receptor","volume":"31","author":"Urayama","year":"2007","journal-title":"Proceedings of the National Academy of Sciences United States of America"},{"key":"10.1016\/bs.apha.2014.06.004_bb0465","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0022-3565(25)10472-2","article-title":"Whole body and brain distribution of [3H]cyclic[D-Pen 2, D-Pen 5] enkephalin after intraperitoneal, intravenous, oral and subcutaneous administration","volume":"263","author":"Weber","year":"1992","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2014.06.004_bb0470","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0022-3565(25)20489-X","article-title":"Distribution and analgesia of [3 H][D-Pen 2, D-Pen 5]enkephalin and two halogenated analogs after intravenous administration","volume":"259","author":"Weber","year":"1991","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2014.06.004_bb0475","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/21548331.1976.11706996","article-title":"Experimental enzyme replacement in genetic and other disorders","volume":"11","author":"Weissmann","year":"1976","journal-title":"Hospital Practice"},{"issue":"5","key":"10.1016\/bs.apha.2014.06.004_bb0480","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/10611860701349141","article-title":"Design and evaluation of a chitosan\u2013aprotinin conjugate for the perioral delivery of therapeutic peptides and proteins susceptible to enzymatic degradation","volume":"15","author":"Werle","year":"2007","journal-title":"Journal of Drug Targeting"},{"issue":"11","key":"10.1016\/bs.apha.2014.06.004_bb0485","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nchembio.664","article-title":"On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds","volume":"7","author":"White","year":"2011","journal-title":"Nature Chemical Biology"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.004_bb0490","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1471-4159.2000.0750424.x","article-title":"Assessment of stereoselectivity of trimethylphenylalanine analogues of \u03b4-opioid [D-Pen2, D-Pen5]-enkephalin","volume":"75","author":"Witt","year":"2000","journal-title":"Journal of Neurochemistry"},{"issue":"84","key":"10.1016\/bs.apha.2014.06.004_bb0495","doi-asserted-by":"crossref","first-page":"84ra44","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.apha.2014.06.004_bb0500","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1155\/2013\/736085","article-title":"Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis","volume":"2013","author":"Zhang","year":"2013","journal-title":"Mediators of Inflammation"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.004_bb0505","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/bs.apha.2014.06.004_bb0510","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0006-8993(92)91098-Y","article-title":"Transport, uptake, and metabolism of blood-borne vasopressin by the blood-brain barrier","volume":"590","author":"Zlokovic","year":"1992","journal-title":"Brain Research"},{"key":"10.1016\/bs.apha.2014.06.004_bb0515","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1006\/bbrc.1993.2582","article-title":"Blood-brain barrier transport of circulating Alzheimer's amyloid","volume":"197","author":"Zlokovic","year":"1993","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.apha.2014.06.004_bb0520","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1471-4159.1989.tb08522.x","article-title":"Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood-brain barrier of an in situ perfused guinea pig brain","volume":"53","author":"Zlokovic","year":"1989","journal-title":"Journal of Neurochemistry"}],"container-title":["Advances in Pharmacology","Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358914000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358914000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:26:24Z","timestamp":1746336384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358914000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9780128002827"],"references-count":103,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2014.06.004","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}